Single Dose Escalating Study of DAS181 in Adults

NCT00527865 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza

Interventions

DRUG: DAS181
DRUG: Placebo

Sponsor

Ansun Biopharma, Inc.

Collaborators

[object Object]